Our blogWell said:
Insights in health & wellness branding
Creativity
NEW CREATIVE CONSIDERATIONS IN THE ERA OF COVID‑19
As pharma companies struggle to define the “new normal,” what does it mean for healthcare agencies trying to depict patients...
by Stephen Neale
May 12
NEW CREATIVE CONSIDERATIONS IN THE ERA OF COVID‑19
As pharma companies struggle to define the “new normal,” what does it mean for healthcare agencies trying to depict patients...
Read full post
April 13
UNDERSTANDING PHYSICIAN ENGAGEMENTS IN A COVID‑19 IMPACTED WORLD
Social distancing has interrupted the flow of information among physicians, their patients and their pharmaceutical partners. Sales rep and...
Read full post
April 7
AbelsonTaylor partners with the MIT COVID19 Challenge 48 Hour Hackathon
The MIT COVID-19 Challenge came to life last weekend. The 48-hour virtual event hosted 1,500 hackers and created 238 teams...
Read full post
March 25
Beat the Pandemic: Virtual Hack Event
Covid19 has become part of our shared, new reality. Even my Republican father and I can agree on that fact....
Read full post
March 23
Navigating your brand through COVID-19
In these days of the COVID-19 epidemic, many in the pharma industry are facing the challenge of accessing their customers...
Read full post
March 2
Inner Workings of an Indoor Alley
When we knew our agency was moving into the newly renovated Old Post Office, we were very excited and had...
Read full post
February 25
Crowdsourcing Hope in Rare Disease Communities
Zebras ahoy! This is the time of year when rare disease patients, caregivers and advocates amplify their voices and increase...
Read full post
February 18
Moving On
We are making our fourth change of address in our almost 40-year history and we are so incredibly, excitedly, on-the-edge-of-our-seats...
Read full post
January 23
Happy New Year: The CCPA is Officially Here
The California Consumer Privacy Act (CCPA) went into effect on January 1, 2020. Learn more about what this means for consumers and organizations and how it compares to GDPR?
Read full post